Stocks
Funds
Screener
Sectors
Watchlists
ONVO

ONVO - Organovo Holdings Inc Stock Price, Fair Value and News

$1.80+0.07 (+4.05%)
Market Closed

46/100

ONVO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

46/100

ONVO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$1.86

Target 3M

$1.89

Target 6M

$1.88

ONVO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ONVO Price Action

Last 7 days

-9.1%

Last 30 days

-8.6%

Last 90 days

-18.4%

Trailing 12 Months

-56.0%

ONVO RSI Chart

ONVO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ONVO Valuation

Market Cap

4.7M

Price/Earnings (Trailing)

-2.37

Price/Sales (Trailing)

33.53

EV/EBITDA

-3.85

Price/Free Cashflow

-0.6

ONVO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$1.86

Target 3M

$1.89

Target 6M

$1.88

ONVO Fundamentals

ONVO Revenue

Revenue (TTM)

140.0K

Rev. Growth (Yr)

-6.67%

Rev. Growth (Qtr)

-24.32%

ONVO Earnings

Earnings (TTM)

-2.0M

Earnings Growth (Yr)

0.16%

Earnings Growth (Qtr)

10.48%

ONVO Profitability

Operating Margin

-635.71%

EBT Margin

-87.50%

Return on Equity

-28.07%

Return on Assets

-20.47%

Free Cashflow Yield

-165.59%

ONVO Investor Care

Shares Dilution (1Y)

103.67%

Diluted EPS (TTM)

0.55

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025144.0K142.0K140.0K0
2024109.0K73.0K103.0K122.0K
2023370.0K445.0K368.0K242.0K
20221.8M01.1M746.7K
20202.2M000
20193.1M3.1M3.4M2.9M
20184.6M4.3M3.9M3.5M
20174.2M4.3M4.3M4.3M
20161.5M2.1M3.1M4.0M
2015571.0K778.0K1.0M1.2M
2014379.0K372.0K399.0K419.0K
20131.3M1.1M693.0K479.0K
2012564.9K650.6K887.6K1.2M
2011513.3K423.6K631.7K645.7K
2010000603.0K
ONVO
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.
 WEBSITEorganovo.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES23

Organovo Holdings Inc Frequently Asked Questions


ONVO is the stock ticker symbol of Organovo Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Tue Jan 27 2026, market cap of Organovo Holdings Inc is 4.69 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check ONVO's fair value in chart for subscribers.

The fair value guage provides a quick view whether ONVO is over valued or under valued. Whether Organovo Holdings Inc is cheap or expensive depends on the assumptions which impact Organovo Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ONVO.

As of Tue Jan 27 2026, ONVO's PE ratio (Price to Earnings) is -2.37 and Price to Sales (PS) ratio is 33.53. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ONVO PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Organovo Holdings Inc has provided -0.425 (multiply by 100 for percentage) rate of return.